PeptideStack
5.2kquestions
20kanswers
220users

Is an ERP order from Zhuhai likely to hold cold chain to the Netherlands?

Asked 15 Mar 2025Modified 13 months agoViewed 24k times
23

Stated plainly: ERP · Zhuhai · the Netherlands.

I would like to set this up properly once, rather than adjust it repeatedly.

My budget is real but not tight, and my tolerance for uncertainty is low.

What would you do, and what would make you change course?

cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

578 questions
international-shipping
international-shipping

Cross-border movement of research material: transit lanes and their thermal profiles, tracked versus untracked, declaration accuracy, and what…

471 questions
vendor-comparison
vendor-comparison

Side-by-side comparison of suppliers on measurable axes - independently confirmed purity and content, lead time, cold-chain handling,…

388 questions
shareeditfollowflag
BN
askedbridget_nyathi12k1515 Mar 2025

5 Answers

Accepted answer first, then by votes
34

Accepted answer

Start with the physical state, because it changes the answer completely and is the first thing to establish.

That is the argument for shipping lyophilised rather than for shipping colder. A dry powder with low residual moisture is stable at ambient for months; the pathways that matter need water.

Anything shipped in solution is a different risk category, because hydrolysis and deamidation proceed in the aqueous phase and are strongly temperature-dependent.

Solid-state stability of lyophilised peptides at ambient temperature is documented in formulation studies with residual moisture as the dominant variable.

A liquefied pack is expected. It is not evidence of a problem.

shareimprove this answerflag
TO
answered · acceptedt_oyelaran79k4812 Jul 2025
5Adding for future readers: the domestic leg after delivery is the part you control. – cold_lane 9 months ago
add a comment
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
31

The short version: a spent cold pack on arrival is expected, the solid does not mind, and the pack was never going to last twelve days.

A single phase-change pack in a thin-walled box holds below ten degrees for roughly one to two days at twenty-five degrees ambient, and under a day at thirty-five. On a nine-to-fourteen-day lane the material is at ambient for most of the journey whatever was packed with it.

Once the parcel arrives, the domestic leg is the controllable part: get it into the refrigerator promptly rather than leaving it in a warm hallway for a day.

Single-use temperature loggers are standard practice in supply chains where temperature genuinely matters and are inexpensive at parcel scale.

Nothing here is medical advice, and research-use compounds are not approved for human use.

The domestic leg is the part you control. Refrigerate it promptly.

edited 5 Jul 2025 by ines_brandt — expanded the table to cover the lower concentration

shareimprove this answerflag
IB
answeredines_brandt113k2571 Jul 2025
4I would add a sentence about light, since tryptophan-containing sequences care. – e_dziedzic 9 months ago
3Does the same reasoning apply to material already in solution, or is that a different curve? – Dr_Jonas_Halvorsen 7 months ago
add a comment
17

Answering this needs the transit duration and the ambient temperature, and then the arithmetic is straightforward.

Asking a supplier to hold a shipment during a heatwave is reasonable and the better ones agree; the cost is a week and the benefit is a shorter warm exposure for anything in solution.

Mechanically, a single-use temperature logger costs a few pounds, records the whole journey and converts an argument into a record. If the history matters, this is the answer.

Arrhenius kinetics predict approximately a doubling of degradation rate per ten-degree rise and are the standard basis for cold-chain design.

Buy a logger if you actually want to know. Everything else is inference.

shareimprove this answerflag
DF
answeredDr_Colm_Fitzhenry69k24725 Mar 2025
8

Answer first: for a lyophilised solid the cold chain matters far less than people believe, and for a solution it matters far more than they act as though it does.

Arrhenius behaviour means the degradation rate roughly doubles per ten degrees. A week at thirty degrees is therefore a meaningful exposure for a solution and an immaterial one for a dry solid.

Phase-change pack hold time is a function of mass, latent heat and insulation, and published figures for small parcels are on the order of one to two days.

The caveat is that a warm transit is survivable for a solid and materially different for a solution.

Lyophilised tolerates the lane. That is the answer for almost every order.

shareimprove this answerflag
TM
answeredtobias_maartens171k35816 Apr 2025
-1

The honest answer is that the cold pack is doing much less than people think and that shipping lyophilised is what actually protects the material.

A pack that arrived hard tells you about the last day of transit only, since it will have melted and, if the ambient dropped, partially refrozen.

Deamidation kinetics for asparagine in peptides are well characterised and strongly sequence-dependent: the residue following the asparagine dominates the rate, with glycine and serine at the n+1 position accelerating it by an order of magnitude relative to bulkier residues. That is why two peptides in the same buffer at the same temperature can have quite different shelf lives.

Reconstituted material has a genuine cold-chain requirement and it starts the moment water is added.

Solutions are a different question and deserve the worry the solids get.

shareimprove this answerflag
ZM
answeredzainab_mustafa21k275 Apr 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.